Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Safety, and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER: Glass 1540nm Laser Module in the Treatment of Acne Scars.

NCT06102343 is registered in ClinicalTrials.gov with Alma Lasers as lead sponsor.

NCT NCT06102343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06102343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Safety, and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER: Glass 1540nm Laser Module in the Treatment of Acne Scars.
Lead sponsor
Alma Lasers
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
January 1, 2025
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne scars - mixed atrophic and hypertrophic